THROMBOCYTOPENIA
Thrombocytopenia is characterized by a decreased platelet count (less than 150,000/mm3), the most common cause of bleeding disorders.
Etiology
- Decreased platelet production
- Infiltrative diseases of bone marrow,
- Leukaemia,
- Aplastic Anemia,
- Myelofibrosis,
- Myelosuppressive therapy,
- Radiation therapy;
- Inherited disorders such as
- Fanconi's anemia (FA, is a rare, inherited blood disorder that leads to bone marrow failure)
- Wiskott-Aldrich syndrome (a rare X-linked recessive disease characterized by eczema, thrombocytopenia, immune deficiency, and bloody diarrhea).
- Increased platelet destruction—
- Infection (eg, HIV or hepatitis C),
- Drug-induced (eg, heparin or quinidine),
- ITP,
- DIC.
- Abnormal distribution or sequestration in spleen.
- Dilutional thrombocytopenia—after haemorrhage, RBC transfusions.
Clinical Manifestations
- Usually asymptomatic (with platelet counts greater than 50,000/mm3).
- When platelet count drops below 20,000/mm3:
- Petechiae occur spontaneously.
- Ecchymoses occur at sites of minor trauma (venipuncture, pressure).
- Bleeding may occur from mucosal surfaces, nose, GI and GU tracts, respiratory system, and within CNS. nasal and gingival bleeding
- Menorrhagia is common.
- Excessive bleeding may occur after procedures (dental extractions, minor surgery, biopsies).
- Thrombotic complications (arterial and venous) and areas of skin necrosis are associated with heparin-induced thrombocytopenia.
Diagnostic Evaluation
- CBC with platelet count
- Haemoglobin —decreased
- Haematocrit—decreased
- Platelets—decreased
- Bleeding time - prolonged.
- Prothrombin time (PT)—prolonged.
- Partial thromboplastin time (PTT)—prolonged.
- Platelet aggregation test for heparin-dependent platelet antibodies—positive.
Medical Management
- Treat underlying cause.
- Platelet transfusions.
- If platelet production is impaired, platelet transfusions may increase the platelet count and stop bleeding or prevent spontaneous hemorrhage.
- If excessive platelet destruction occurs, transfused platelets are also destroyed, and the platelet count does not increase. The most common cause of excessive platelet destruction is idiopathic thrombocytopenic purpura.
- Steroids or IV immunoglobulins may be helpful in selected patients.
- Heparin-induced thrombocytopenia:
- Discontinue heparin,
- Use alternate anticoagulant therapy due to high risk of venous and arterial thromboses in these patients (direct thrombin inhibitors, such as lepirudin or argatroban hirudin),
- Avoid platelet transfusions.
Nursing management
Risk for Injury related to bleeding due to thrombocytopenia.
- Institute bleeding precautions.
- Avoid use of plain razor, hard toothbrush or floss, I.M. injections, tourniquets, rectal procedures, suppositories.
- Administer stool softeners, as necessary, to prevent constipation.
- Restrict activity and exercise when platelet count is less than 20,000/mm3 or when active bleeding occurs.
- Monitor pad count and amount of saturation during menses;
- Administer or teach self-administration of hormones to suppress menstruation, as prescribed.
- Administer blood products, as ordered.
- Monitor for signs and symptoms of allergic reactions, anaphylaxis, and volume overload.
- Evaluate urine, stools, and emesis for gross and occult blood.
Comments
Post a Comment